Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126916171 | 12691617 | 1 | I | 20160817 | 20160826 | 20160826 | EXP | JP-009507513-1608JPN010984 | MERCK | 0.00 | E | F | Y | 0.00000 | 20160826 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126916171 | 12691617 | 1 | PS | REMERON | MIRTAZAPINE | 1 | Oral | 0.5 DF, UNK | 20415 | .5 | DF | TABLET | |||||||
| 126916171 | 12691617 | 2 | SS | REMERON | MIRTAZAPINE | 1 | Oral | 1 DF, UNK | 20415 | 1 | DF | TABLET | |||||||
| 126916171 | 12691617 | 3 | SS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | 50 MG, BID, IN EVENING AND MORNING | U | 0 | 50 | MG | TABLET | BID | |||||
| 126916171 | 12691617 | 4 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | DAOILY DOSAGE UNKNOWN | U | 0 | ORAL POWDER | ||||||||
| 126916171 | 12691617 | 5 | SS | BI SIFROL | PRAMIPEXOLE | 1 | Oral | 3 DF, UNK | 0 | 3 | DF | ORAL POWDER | |||||||
| 126916171 | 12691617 | 6 | SS | BI SIFROL | PRAMIPEXOLE | 1 | Oral | 2 DF, UNK | 0 | 2 | DF | ORAL POWDER | |||||||
| 126916171 | 12691617 | 7 | SS | AMLODIN | AMLODIPINE BESYLATE | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | |||||||||
| 126916171 | 12691617 | 8 | C | LUNESTA | ESZOPICLONE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | ORAL POWDER | |||||||||
| 126916171 | 12691617 | 9 | C | MEILAX | ETHYL LOFLAZEPATE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | ORAL POWDER | |||||||||
| 126916171 | 12691617 | 10 | C | NAUZELIN | DOMPERIDONE | 1 | Unknown | DAILY DOSAGE UNKNOWN | 0 | ||||||||||
| 126916171 | 12691617 | 11 | C | SELBEX | TEPRENONE | 1 | Unknown | DAILY DOSAGE UNKNOWN | 0 | ||||||||||
| 126916171 | 12691617 | 12 | C | GASTER | FAMOTIDINE | 1 | Oral | DAILY DOSAGE UNKNOWN | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126916171 | 12691617 | 3 | Parkinson's disease |
| 126916171 | 12691617 | 4 | Depression |
| 126916171 | 12691617 | 5 | Parkinson's disease |
| 126916171 | 12691617 | 7 | Angina pectoris |
| 126916171 | 12691617 | 8 | Insomnia |
| 126916171 | 12691617 | 9 | Insomnia |
| 126916171 | 12691617 | 10 | Gastrointestinal disorder |
| 126916171 | 12691617 | 11 | Gastrointestinal disorder |
| 126916171 | 12691617 | 12 | Gastrointestinal disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126916171 | 12691617 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126916171 | 12691617 | Angina pectoris | |
| 126916171 | 12691617 | Asthenia | |
| 126916171 | 12691617 | Cataract | |
| 126916171 | 12691617 | Chest discomfort | |
| 126916171 | 12691617 | Diarrhoea | |
| 126916171 | 12691617 | Gastrointestinal disorder | |
| 126916171 | 12691617 | Lacrimation increased | |
| 126916171 | 12691617 | Parkinson's disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126916171 | 12691617 | 3 | 201605 | 0 |